Antitrust Compliance and Clinical Integration: Recent Developments, FTC and DOJ Scrutiny

While talk of change on Capitol Hill continues on healthcare, one consistency is that healthcare providers around the country still seek out ways to better collaborate and coordinate care. Accountable care organizations and other forms of clinical and financial integration are the most common types of collaborations other than mergers and acquisitions. However, competitor collaborations can raise antitrust concerns. The FTC, DOJ, state attorneys general, and other market participants are scrutinizing these arrangements to ensure compliance with antitrust laws.

The speakers will describe how the FTC investigates collaborations among providers such as ACOs and clinically integrated networks. They will discuss collaborative activities that are unlikely to raise antitrust concerns and the types of situations that are likely to prompt an investigation. They will address how to reduce antitrust risks in forming and operating a physician network, joint venture, or ACO, and how best to respond to an antitrust investigation if one occurs.

Listen as our authoritative speakers provide practical guidance on how to assess the antitrust risks of provider collaborations and how to reduce the likelihood of an antitrust investigation or challenge.